Latest News
Align Capital Partners (ACP) has made a growth capital investment in WilliamsMarston, an accounting advisory and management consulting firm with offices in Boston and New York. Co-Founders Landen Williams and Jon Marston will continue to lead the Firm through its next phase of growth.
WilliamsMarston provides public, private equity-backed and pre-IPO companies with specialised consulting services including transaction support in M&A, divestitures, initial public offerings and restructuring as well as technical accounting, interim management and process improvement. “Jon and I founded WilliamsMarston on the premise that many companies, their investors, lenders and other stakeholders were underserved in the accounting advisory space,”
Oppenheimer & Co, an investment bank, wealth manager and a subsidiary of Oppenheimer Holdings, has appointed Jarl Berntzen as a managing director in the firm’s Global Technology Investment Banking Group with a primary focus on providing strategic advisory services to companies in the vertical SaaS and data services markets. Berntzen will be based in San Francisco, reporting to Robin Graham, Head of Technology, Media, and Communications Investment Banking. Berntzen is another addition to an extensive list of experienced investment banking professionals recently hired to cover the software sector.
”We’re extremely pleased to welcome Jarl to our Global Technology franchise. His
IQ Capital has led a GBP 5.5 million series A funding round in CyberSmart, which helps small to medium-sized businesses combat cyber-attacks.
The fresh capital will be used to fund CyberSmart’s growth, which has seen an increase in demand with a revenue increase of 300 per cent over the past 12 months, as the lockdown accelerated the use of its cloud-based technology, according to the company.
“We are delighted to have closed our Series A funding round with GBP 5.5 million to fund our next stage of growth. Our investors have seen that we have built a great technology and
iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, has raised an additional EUR5.1 million bringing its total Series A financing to EUR20.1 million. New investor 3B Future Health Fund, previously known as Helsinn Investment Fund, SICAR joins the existing blue chip investor syndicate of M Ventures, INKEF Capital, VI Partners, and Schroder Adveq, which all participated in the extension.
The funding will enable iOnctura to accelerate development of its next generation dual immune and tumour targeting therapies. Data emerging from early clinical evaluation of its lead molecule IOA-244, a highly selective
Mid-market private equity investor LDC says there are signs transaction activity had started to rebound as more companies looked beyond the impact of the pandemic to long-term growth and diversification strategies.In a half-year update, the firm announced it had backed a total of 18 investments in the first half of 2020. The majority completed since the onset of the pandemic, with momentum increasing as eight deals closed in the past four weeks alone, and its pipeline for the second half of the year building quickly.
LDC, which plans to invest GBP1.2 billion of capital over the next three years, says
Munich Private Equity Partners (MPEP) has closed its third private equity program at EUR 162 million with renowned international investors. The original target for MPEP III was EUR100 million.
MPEP launches a new private equity program approximately every 18 months. Benefiting from the relationship with its anchor investor, the mid-cap buyout specialist is able to build up substantial parts of the fund portfolios before it begins active fundraising with institutional investors. Therefore, potential investors receive favourable visibility on the manager quality and expected portfolio composition, consequently the blind pool risk typically associated with such investments is substantially reduced compared to
TrueBridge Capital Partners has closed its sixth venture capital fund-of-funds, TrueBridge Capital Partners Fund VI, with USD600 million in capital from LPs.
Investors into TrueBridge Fund VI include new and existing global LPs, including foundations and endowments, pension funds, family offices, as well as high net worth individuals.
With this latest fund, TrueBridge now manages over USD3.3 billion in assets. “Today’s global economic environment is one with a truly unprecedented level of uncertainty. Now more than ever, there is a tremendous need and opportunity to connect venture capitalists and entrepreneurs as they pioneer new technologies to better navigate our evolving
In this webinar, we ask how a data-driven approach to legal spending helps PE groups strategise weeks and months ahead of time as well as achieve greater overall visibility on costs, benefiting the fund and investors alike.
In part 2 of Episode 8, Nicholas d’Adhemar and Charlotte Henderson make predictions about the future of the legal profession. They share their thoughts on the long-term impact of the Covid-19 crisis on capital solutions, how the way in-house legal teams collaborate internally and externally will change over time, and what the biggest pressure felt by GSs in the next few years is going to be…
Kester Capital’s (Kester) portfolio company Frontier Medical, has sold its Infection Prevention business in a carve-out to Vernacare, backed by HIG Capital. The deal includes the brands Sharpsafe, Clinisafe and eXchange. Terms of the transaction have not been disclosed.
The exited businesses are industry-leaders in the Infection Prevention market providing an extensive range of sharps and clinical waste disposal solutions. Sharpsafe was the world’s first purpose-designed plastic sharps container. With a customer base across the UK and Europe, the business operates from its site in Blackwood, Wales.
Frontier’s core division, Frontier Therapeutics, a leading provider of differentiated Skin and
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
